Gastrointestinal Imaging Original Research
|
|
- Rudolf Cannon
- 5 years ago
- Views:
Transcription
1 Gastrointestinal Imaging Original Research Arita et al. Gastrointestinal Imaging Original Research Junichi Arita 1 Kiyoshi Hasegawa Michiro Takahashi Shojiro Hata Junichi Shindoh Yasuhiko Sugawara Norihiro Kokudo Arita J, Hasegawa K, Takahashi M, et al. Keywords: contrast-enhanced ultrasound, hepatocellular carcinoma (HCC), histologic grade, intraoperative ultrasound, microbubbles, perfluorobutane, Sonazoid DOI: /AJR Received January 21, 2010; accepted after revision November 10, This work was supported in part by a grant-in-aid ( ) for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Tokyo; a grant-in-aid (H20-hepatitis-general-001) for research on the development of early detection systems for liver cancer using molecular markers and diagnostic imaging from the Ministry of Health, Labor, and Welfare of Japan, Tokyo; and a grant from the Japanese Society for Advancement of Surgical Techniques, Osaka. 1 All authors: Divisions of Hepato-Biliary-Pancreatic Surgery and Artificial Organ and Transplantation, Department of Surgery, Graduate School of Medicine, University of Tokyo, Hongo, Bunkyo-ku, Tokyo, , Japan. Address correspondence to J. Arita (jarita-tky@umin.ac.jp). AJR 2011; 196: X/11/ American Roentgen Ray Society Correlation Between Contrast- Enhanced Intraoperative Ultrasound Using Sonazoid and Histologic Grade of Resected Hepatocellular Carcinoma OBJECTIVE. Our aim was to accurately assess the correlation between findings of contrast-enhanced intraoperative ultrasound using Sonazoid and histologic grade of hepatocellular carcinoma (HCC). SUBJECTS AND METHODS. We enrolled 239 consecutive patients who were undergoing surgery for HCC for this study. Because 33 extensively necrotic HCCs were excluded, a total of 374 histologically proven HCCs were detected in all resected specimens and were the study subjects (71 well-differentiated, 239 moderately differentiated, and 64 poorly differentiated HCCs). After a laparotomy and liver mobilization, contrast-enhanced intraoperative ultrasound in the harmonic mode was performed after a Sonazoid injection. The first minute was defined as the vascular phase, in which the vascularity of the 239 HCCs was assessed. After an approximately 15-minute delay, a thorough liver exploration was performed (Kupffer phase). Preoperative dynamic CT was routinely performed, and the findings were assessed for reference. RESULTS. The proportion of hypervascular tumors during the vascular phase tended to be lower among well-differentiated than among moderately and poorly differentiated HCCs (66% vs 80%, p = 0.058). The proportion of hypoechoic tumors during the Kupffer phase was significantly lower among well-differentiated than among moderately and poorly differentiated HCCs (54% vs 92%, p < ). In dynamic CT, the proportions of hypervascular tumors during the early phase and hypodense tumors during the late phase were significantly lower among well-differentiated HCCs than among moderately and poorly differentiated HCCs, respectively (early phase, 51% vs 87%, p < ; late phase, 59% vs 85%, p < ). CONCLUSION. Contrast-enhanced intraoperative ultrasound using Sonazoid is useful for estimating the histologic grade of HCC. H epatocellular carcinoma (HCC) is one of the most common cancers worldwide and is a major cause of death in patients with cirrhosis [1]. The histologic grade of HCC strongly correlates with tumor activity [2] and thus is an established prognostic factor [3, 4]. Well-differentiated HCCs less frequently exhibit vascular invasion and intrahepatic metastasis [5 8]. Therefore, estimating the histologic grade of HCC is helpful for selecting a treatment strategy. Contrast-enhanced ultrasound has been developed for a differential diagnosis of focal liver lesions found in cirrhotic patients [9 12]. Two widely used contrast agents for ultrasound, gaseous perflutren (Definity, Bristol-Myers Squibb) and gaseous sulfur hexafluoride (SonoVue, Bracco) are both pure intravascular contrast agents [13]. Gaseous perfluorobutane (Sonazoid, GE Healthcare) is also a second-generation contrast agent that has recently become commercially available in Japan. It is not a pure intravascular contrast agent but has the peculiarity of accumulating in Kupffer cells in the liver [13 15] and thus enables Kupffer imaging in addition to showing tumor vascularity [16]. Superparamagnetic iron oxide (SPIO) enhanced MRI, which also enables Kupffer imaging, has been reported to be well correlated with the histologic grade of HCC [17 19]. Two studies have compared Kupffer phase images of contrast-enhanced ultrasound using Sonazoid and SPIO-enhanced MRI and shown good agreement for both images [20, 21]. One of the two studies further compared the histologic grade of HCC with Kupffer phase images of contrast-enhanced ultrasound using Sonazoid and showed fair correlation; however, they assessed 1314 AJR:196, June 2011
2 only 48 HCCs, including as few as 13 welldifferentiated HCCs, and, moreover, the majority of the specimens for histologic grading were obtained by needle biopsy instead of surgical resection [21]. Histologic examination of a resected specimen is preferable to that of a needle biopsy specimen because the latter yields up to 30% of false-negative findings among small HCCs [22 24] and both methods show low compatibility in the histologic grading of HCC [25]. In this study, findings of contrast-enhanced intraoperative ultrasound using Sonazoid for surgically resected HCCs were compared with their histologic grade. Contrast enhanced ultrasound was performed in an intraoperative setting to secure a precise evaluation of ultrasound images, avoiding dead angles, breath motion artifact, and ultrasonic attenuation through the abdominal wall. Subjects and Methods Patients The study protocol conformed to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institutional review board. This study was conducted in accordance with a prospective protocol. Two hundred ninety-four consecutive patients who were scheduled to undergo surgery for HCC between February 7 and September 9 were considered for enrollment in the study. Of them, 55 patients were excluded from the study for the following reasons: absence of informed consent in 30 patients, unavailability of the required devices in eight, or the number of histologically proven HCCs was more than nine in 17 (a precise assessment by histology or by imaging studies was impossible because of possible numerous tiny intrahepatic metastases). The remaining 239 patients were enrolled in the study. Written informed consent was obtained from each patient included in the study. The baseline characteristics of the enrolled patients are summarized in Table 1. Diagnosis of HCC All specimens resected in the enrolled patients were fixed in formalin, sectioned serially, stained with H and E, and examined by two expert pathologists per patient on the basis of the criteria of the International Working Party [26]. Tumors were not excluded on the basis of size or depth considering the advantages of intraoperative ultrasound [27]. In total, 407 histologically proven HCCs were detected among the 239 patients. For a precise assessment of histologic grade, 33 HCCs were excluded from the analysis because more than two thirds of the entire lesion was necrotic. Thus, the remaining 374 tumors were included in this study. TABLE 1: Characteristics of Patients Characteristics Values Sex Men 198 Women 41 Age a (y) 68 (21 86) HBsAg 48 HCVAb 120 Both HBsAg and HCVAb 1 Neither HBsAg or HCVAb 72 Background liver Normal liver 11 Chronic hepatitis 138 Liver cirrhosis 90 Number of HCCs b (1/2/3/4 or more) Size of largest HCC a (cm) 2.7 ( ) Note Values are expressed as number. HBsAg = hepatitis B surface antigen, HCVAb = hepatitis C virus antibodies, HCC = hepatocellular carcinoma. a Values are expressed as median (range). b Including extensively necrotic tumors. The cellular differentiation of HCC was graded as either of well-, moderately, or poorly differentiated on the basis of the above-mentioned criteria [26]. When a tumor had several components with the various cellular differentiations, the histologic grade of the tumor was decided according to the lowest cellular differentiation among all components. This arrangement is based on the following consideration: a component of lower cellular differentiation is more hypervascular [10, 28, 29] and has fewer Kupffer cells [17 19, 30, 31] in general and thus more strongly influences the contrast-enhanced intraoperative ultrasound characterization of the tumor. Consequently, 374 tumors were classified as 71 well-, 239 moderately, and 64 poorly differentiated HCCs; the median (range) size of the tumors was 1.4 cm ( cm), 1.8 cm ( cm), and 2.5 cm ( cm), respectively. Dynamic CT Preoperative dynamic CT was routinely performed in the patients with HCC, and the findings were also assessed as a reference. The CT systems used in this study consisted of 4-, 8-, or 16-MDCT scanners (Aquilion 4 and Aquilion 16, Toshiba; LightSpeed Qx/i and LightSpeed Ultra, GE Healthcare). After conventional CT, dynamic contrast-enhanced CT was performed with a bolus injection of iodinated contrast agent using a mechanical power injector; 2 ml/kg body weight (maximum, 100 ml) of contrast agent at a concentration of mg I/mL was injected in 30 seconds through the antecubital vein. CT was performed at 25, 45, and 120 seconds after starting the injection. The former was referred to for the assessment in the early phase and the latter in the late phase. Reconstruction images were obtained with a section thickness of mm and a section interval of mm. A focal liver lesion was categorized as either hyper-, iso-, or hypovascular during the early phase and categorized as either hyper-, iso-, or hypodense during the late phase compared with the surrounding liver parenchyma in consensus between two expert radiologists who were in charge for a given patient. A focal liver lesion that was hard to differentiate from the surrounding liver was categorized as iso- in both phases. Contrast-Enhanced Intraoperative Ultrasound The ultrasound system Prosound α10 (Aloka) was used for all fundamental intraoperative ultrasound and contrast-enhanced intraoperative ultrasound procedures. A microconvex probe dedicated to intraoperative ultrasound, UST-9132 (Aloka), with a 3.75-MHz transmit and receive center frequency, was used for all baseline fundamental intraoperative ultrasound examinations. A microconvex probe dedicated to intraoperative contrast-enhanced AJR:196, June
3 Arita et al. A Fig year-old man with liver cirrhosis who had moderately differentiated hepatocellular carcinoma in segment V of liver, 1.8 cm in diameter. Left side of ultrasound images shows referential fundamental view and right side shows harmonic view. A, Intraoperative contrast-enhanced ultrasound image obtained during vascular phase shows focal liver lesion strongly enhanced at 40 seconds after contrast injection (arrows). B, Contrast-enhanced intraoperative ultrasound during Kupffer phase approximately 16 minutes after contrast injection shows well-delineated hypoechoic focal liver lesion (arrowheads). Fig year-old man with chronic hepatitis who had hepatocellular carcinoma in segment VI of liver, 6.5 cm in diameter. Left side shows fundamental view and right side shows harmonic view. During vascular phase, unpaired arteries (arrows) are seen in tumor with margins indicated by arrowheads. ultrasound, UST-9133 (Aloka), was used for all contrast-enhanced intraoperative ultrasound procedures; the transmit center frequency of this probe was 1.88 MHz and the receive center frequency was 3.75 MHz. Contrast-enhanced intraoperative ultrasound was performed in the Extended Pure Harmonic Detection Mode (Aloka), a harmonic mode dedicated to microbubble detection. The frame rate was 63 Hz in the fundamental mode and 15 Hz in the harmonic mode. The mechanical index was set at 0.2 in all contrast-enhanced intraoperative ultrasound procedures. The acoustic power was automatically altered to keep the mechanical index at 0.2 as the depth of the focus point altered. During all contrast-enhanced intraoperative ultrasound procedures, a real-time fundamental mode image was displayed simultaneously with a harmonic mode image side-by-side for reference (Dual Dynamic Monitor Mode, Aloka) (Figs. 1 and 2). Thus, the target focal liver lesions were not missed even if they were hard to recognize in the harmonic mode. The gain and time-gain controls were set at the optimal settings before the contrast injection and were not altered thereafter. In the harmonic mode, an echo signal from within 1 cm of the probe was hard to recognize, so a 1-cm-thick sterilized gelatin sheet (Sonar Aid, Geistlich Pharma) was placed on the liver surface as an ultrasonic medium. All ultrasound procedures during operations were performed by one of four physicians who each had more than 5 years of experience performing intraoperative ultrasound examinations. After a laparotomy and liver mobilization, fundamental intraoperative ultrasound was performed to confirm the preoperative tumor staging. Then, Sonazoid was injected at a dose of 0.12 μl of microbubbles/kg of body weight through the antecubital vein in about 1 second. After injection, one focal liver lesion per injection was continuously observed in the harmonic mode for 1 minute (vascular phase), and the tumor vascularity was categorized as hypervascular, isovascular, or hypovascular. A focal liver lesion was categorized as hypervascular when all or a part of it turned hyperechoic compared with the surrounding liver parenchyma (Fig. 1A) or when unpaired dysmorphic vessels were observed within it [32, 33] (Fig. 2). Isovascular and hypovascular were defined as when a focal liver lesion was isoechoic and hypoechoic, respectively, at its maximal enhancement compared with the surrounding liver parenchyma. The focus was set at the level just below the approximate bottom of the target focal liver lesion. The ultrasonic observation was not extended beyond 1 minute after injection. One reason is that as microbubbles accumulated in the Kupffer cells the surrounding liver obviously increased its echogenicity in approximately 1 minute after injection, thus interfering with an assessment of tumor vascularity. Another reason is as follows: The acoustic power is rather high at the mechanical index of 0.2, and the same plane is continuously insonated for 1 minute. Therefore, microbubbles in the surrounding liver as well as the targeted focal liver lesion start to be destroyed, which interferes with a comparison of echogenicity between them. After an approximately 15-minute delay after the vascular phase, ultrasonic observation was commenced again in the harmonic mode to examine the entire liver; this period was defined as the Kupffer phase. During the pause after the vascular phase, surgical procedures that did not influence later contrast-enhanced intraoperative ultrasound were allowed. Hypoechoic focal liver lesions were searched for in the hyperechoic surrounding liver with accumulated microbubbles (Fig. 1B). Repeated scans were available; the contrast effect has been reported to be maintained at least 30 minutes after injection [34]. The focus point was set at the bottom of the liver. One additional injection of Sonazoid at the same dose was allowed to assess the vascularity of another focal liver lesion after surveillance in the Kupffer phase. Therefore, a maximum of two focal liver B 1316 AJR:196, June 2011
4 Vascular phase examined (n = 234) Detected in preoperative imaging (n = 329) Kupffer phase examined (n = 343) Resection (n = 352) Study subject (n = 374) Vascular phase not examined (n = 109) lesions per patient was examined in the vascular phase. The observation in the Kupffer phase was not repeated after the second injection because all focal liver lesions were theoretically examined by a thorough scan in the first Kupffer phase. A flowchart of all subject tumors, which summarizes examination procedures, is shown in Figure 3. Not all lesions examined during the vascular phase were included in the study subjects because some were not resected and others were resected but histologically diagnosed as benign. The 22 tumors found in resected specimens during histologic examination were considered isoechoic during the Found during Kupffer phase (n = 9) Vascular phase examined (n = 5) Found during intraoperative ultrasound (n = 14) Vascular phase not examined (n = 4) Found in resected specimen (n = 22) Fig. 3 Flow chart summarizes examination profile of all subject tumors. In total, 239 tumors were examined during vascular phase of contrast-enhanced intraoperative ultrasound. During Kupffer phase, all possible focal liver lesions were theoretically examined (n = 374). Tumors found in resected specimen (n = 22) were categorized as isoechoic. Kupffer phase because they had not been differentiated from the surrounding liver. For precise localization of a focal liver lesion, relation with up to the fourth order portal branch, i.e., next branching of Couinaud segment, was described, or the liver capsule was marked with electrocautery referring to intraoperative ultrasound. All contrast-enhanced intraoperative ultrasound categorization was performed prospectively during the operation in consensus between two of the four physicians. Tumor characterization by an offsite observer was not performed in this study because the surgical strategies were decided partially referring to the categorization. Statistics All statistical analyses were performed with the help of the commercially available software (PASW Statistics , SPSS) for Microsoft Windows. The Fisher exact test was applied for comparing proportions. Statistical significance was assessed using a two-tailed test at p < Results A total of 407 histologically proven HCCs were detected among all 239 enrolled patients. Because 33 extensively necrotic HCCs were excluded, the subjects of this study included 374 HCCs, which consisted of 71 well-differentiated, 239 moderately differentiated, and 64 poorly differentiated HCCs. Ultrasonic observation during the vascular phase was done in all 239 patients; vascularity of one or two focal liver lesions, whether benign or malignant, was examined in each patient. Among those lesions for which vascularity was examined, 239 were included in the subjects of this study, which corresponded to 64% of all 374 HCCs. Of the 239 lesions, 187 were observed after the first injection of Sonazoid and 52 after the second injection. During the Kupffer phase, all 374 HCCs were theoretically examined because the entire liver was explored through repeated scans. Findings of contrast-enhanced intraoperative ultrasound among HCCs classified by histologic grade are shown in Table 2. Of the 239 HCCs examined during the vascular phase of contrast-enhanced intraoperative ultrasound, 186 (78%) were hy- TABLE 2: Findings of Contrast-Enhanced Intraoperative Ultrasound Among Hepatocellular Carcinoma (HCC) Classified by Histologic Grade Contrast-Enhanced Intraoperative Ultrasound Findings Hypervascular Well-Differentiated HCC Moderately Differentiated HCC Poorly Differentiated HCC (n = 64) Total (n = 374) Kupffer hypoechoic Kupffer isoechoic Isovascular Kupffer hypoechoic Kupffer isoechoic Hypovascular Kupffer hypoechoic Kupffer isoechoic Vascular not examined Kupffer hypoechoic Kupffer isoechoic AJR:196, June
5 Arita et al. 250 Not examined Hypovascular Isovascular Hypervascular 250 Isoechoic Hypoechoic 18 No Well 124 pervascular, 34 (14%) were isovascular, and 19 (8%) were hypovascular (Table 2). The vascular phase findings of each histologic grade are summarized in Figure 4. The proportion of hypervascular tumors among well-differentiated HCCs was 66% (25/38) and tended to be lower than that of 80% (161/201) among moderately and poorly differentiated HCCs, although the difference failed to reach statistical significance (p = 0.058, Fisher exact test), whereas the proportion of hypervascular tumors among moderately differentiated HCCs was 79% (124/156) and was similar to that of 82% (37/45) among poorly differentiated HCCs (p = 0.83, Fisher s exact test). During the Kupffer phase of contrast-enhanced intraoperative ultrasound, 318 (85%) of all 374 HCCs were hypoechoic (Table 2). The Kupffer phase findings among each histologic grade are summarized in Figure 5. The proportion of hypoechoic tumors among well-differentiated HCCs was 54% (38/71) and significantly Moderately Differentiated Poorly (n = 64) Fig. 4 Graph shows proportions of tumors with each finding during vascular phase of contrast-enhanced ultrasound among each histologic grade of hepatocellular carcinoma (HCC). Hypervascular tumors were significantly less frequent among well-differentiated than moderately and poorly differentiated HCC. 3 No lower than that of 92% (280/ 303) among moderately and poorly differentiated HCCs (p < , Fisher exact test), whereas the proportion of hypoechoic tumors among moderately differentiated HCCs was 92% (221/239) and similar to that of 92% (59/64) among poorly differentiated HCCs (p = 1.00, Fisher exact test). Because 10 patients who had an allergy to iodinated contrast agents were excluded, 229 patients underwent dynamic CT. Dynamic CT findings during the early phase are summarized in Figure 6. The proportion of hypervascular tumors among well-differentiated HCCs was 51% (36/71) and significantly lower than that of 87% (253/291) among moderately and poorly differentiated HCCs (p < ). Dynamic CT findings during the late phase are summarized in Figure 7. The proportion of hypodense tumors among well-differentiated HCCs was 59% (42/71) and significantly lower than that of 85% (247/291) among moderately and poorly differentiated HCCs (p < , Fisher exact test) Well 221 Moderately Differentiated Of the 239 HCCs that were examined in both phases of contrast-enhanced intraoperative ultrasound, 11 were neither hypervascular in the vascular phase nor hypoechoic in the Kupffer phase, i.e., diagnostic findings for HCC were absent during both phases. The characteristics of the 11 tumors are summarized in Table 3. The median size of the 11 tumors was 1.5 cm. Among the 11 tumors, seven (64%) were well-differentiated HCC and the other four tumors were well- or moderately differentiated HCC, of which a major component was well-differentiated tumors. The classic pattern for HCC in dynamic CT, i.e., concomitantly hypervascular during early phase and hypodense during late phase, was seen only in three of 11 tumors. Discussion This study showed that findings during both the vascular and Kupffer phases of contrast-enhanced intraoperative ultrasound using Sonazoid are correlated with the histologic grade of HCC. In particular, such correlation was 5 59 Poorly (n = 64) Fig. 5 Graph shows proportions of tumors with each finding during Kupffer phase of contrast-enhanced ultrasound among each histologic grade of hepatocellular carcinoma (HCC). Hypoechoic tumors were significantly less frequent among well-differentiated than moderately and poorly differentiated HCC AJR:196, June 2011
6 No Not examined Hypovascular Isovascular Hypervascular Well Moderately Differentiated found stronger for the Kupffer phase. Moderately and poorly differentiated HCCs more frequently showed hypervascular findings during the vascular phase and hypoechoic findings during the Kupffer phase than welldifferentiated HCCs did. On the other hand, moderately and poorly differentiated HCCs showed similar findings during both the vascular and Kupffer phases of contrast-enhanced intraoperative ultrasound. These results could be applicable to contrast-enhanced ultrasound in clinical settings. Estimating the histologic grade is helpful for clinical management of patients with HCC. Well-differentiated HCC less frequently induces intrahepatic metastasis through vascular invasion than do moderately and poorly differentiated HCC [5 8], thus surgeons could select a nonanatomic resection when a tumor is estimated to be well differentiated, and conversely, an anatomic resection would be selected to eradicate possible intrahepatic metastasis. For a similar reason, when a patient has solitary HCC with a marginal size, 9 53 Poorly (n = 64) Fig. 6 Graph shows proportions of tumors with each finding during early phase of dynamic CT among each histologic grade of hepatocellular carcinoma (HCC). Hypervascular tumors were significantly less frequent among well-differentiated than moderately and poorly differentiated HCC. 2 No Not examined Hyperdense Isodense Hypodense a physician could confidently select either hepatic resection or local ablation using the information regarding histologic grade. A hypervascular finding during the vascular phase of contrast-enhanced intraoperative ultrasound was more frequent among moderately and poorly differentiated HCCs (80%) than among well-differentiated HCCs (66%) in this study, although the difference barely failed to reach statistical significance, perhaps because of the small sample size. A study of contrast-enhanced ultrasound using Definity reported similar findings (well-differentiated, 61%; moderately and poorly differentiated, 94%) [28], whereas three studies using SonoVue reported that the proportion of hypervascular findings among well-differentiated HCCs (82 100%) was higher than that in this study, and the proportion was not significantly different from moderately and poorly differentiated HCCs (96 100%) [10, 29, 35]. Such a discrepancy may be caused partly by the difference of the tumor size. The median size of the subject tumors in the Well Moderately Differentiated current study was 1.5 cm and rather smaller compared with those of the three studies using SonoVue, which were 2.7 cm [10], 5.88 cm [29], and 3.8 cm [35]. Other possible causes included the difference of contrast medium or type of harmonic mode; however, an explanatory mechanism is yet to be found. The hypervascular findings of dynamic CT were also more frequent among moderately and poorly differentiated HCCs than among well-differentiated HCCs. This result was similar to the reports that claimed early phase findings of dynamic CT are well correlated with histologic grade [36 39]. This finding would indicate that the results of the study subjects of the current study would be worth comparing with other studies, although the median diameter, about 1.8 cm, was relatively small. A hypoechoic finding during the Kupffer phase of contrast-enhanced intraoperative ultrasound was more frequent among moderately and poorly differentiated HCCs than among well-differentiated HCCs in this study. Similar Poorly (n = 64) Fig. 7 Graph shows proportions of tumors with each finding during late phase of dynamic CT among each histologic grade of hepatocellular carcinoma (HCC). Hypodense tumors were significantly less frequent among well-differentiated than moderately and poorly differentiated HCC. AJR:196, June
7 Arita et al. TABLE 3: Hepatocellular Carcinoma (HCC) Without Diagnostic Findings During Both Phases of Contrast-Enhanced Intraoperative Ultrasound Tumor Liver Size (cm) Depth (cm) CT Early CT Late Histologic Grade 1 Liver cirrhosis Hypointense Hypointense Well-differentiated 2 a Chronic hepatitis Isointense Isointense Well-differentiated 3 a Chronic hepatitis Isointense Isointense Well-differentiated 4 a Chronic hepatitis Hypointense Hypointense Well-differentiated 5 a Chronic hepatitis Hypointense Hypointense Well-differentiated 6 Liver cirrhosis Hypointense Hypointense Well-differentiated 7 Chronic hepatitis Hypointense Hypointense Well to moderately differentiated 8 Liver cirrhosis Hyperintense Hypointense Well to moderately differentiated 9 Liver cirrhosis Hyperintense Isointense Well-differentiated 10 Chronic hepatitis Hyperintense Hypointense Well to moderately differentiated 11 Chronic hepatitis Hyperintense Hypointense Well to moderately differentiated a Tumors 2 and 3 were found in the same patient, and tumors 4 and 5 were found in the same patient. results were reported by Korenaga et al. [21], who assessed Kupffer phase images of contrast-enhanced ultrasound using Sonazoid for 48 histologically proven HCCs. The echogenicity ratio of tumor against liver parenchyma was calculated in the study; the mean ratio for well-differentiated HCCs was 0.84 and was significantly higher than that for moderately differentiated HCCs (0.43) and poorly differentiated HCCs (0.30). The current study has corroborated the difference of findings during the Kupffer phase between well-differentiated HCCs and moderately and poorly differentiated HCCs, with a larger number of tumors, including as many as 71 well-differentiated HCCs and exclusively using resected specimens for histologic grading. The reason for the discrepancy among histologic grades may be that well-differentiated HCCs possess a comparable number of Kupffer cells to liver parenchyma, whereas moderately and poorly differentiated HCCs possess fewer or none [17, 18, 30]. In this study, a hypodense finding during the late phase of dynamic CT was significantly more frequent among moderately and poorly differentiated HCCs than among welldifferentiated HCCs, whereas the proportions were similar between moderately differentiated HCCs and poorly differentiated HCCs. Two studies reported similar results [37, 39] and another reported that proportions of hypodense tumors were equivalently high among three histologic grades [38]. This discrepancy may be explained by the difference of scan timing; the current study and the former two adopted seconds for the interval, whereas the latter study used 300 seconds. Therefore, the results of the current study seemed acceptable. Well-differentiated HCCs were dominant among the 11 HCCs that were neither hypervascular in the vascular phase or hypoechoic in the Kupffer phase (Table 2). As many as nine of 39 well-differentiated HCCs (32%) examined in both phases corresponded to such cases. The median size of the 11 tumors was 1.3 cm and similar to that of all tumors (1.5 cm). Therefore, the lack of diagnostic findings could not be attributed to the small size of tumors. Given that most of the 11 tumors also lacked the classic pattern in dynamic CT, such tumors would be at an early stage of the cellular dedifferentiation pathway. One of the drawbacks of this study is that all HCCs were not examined during the vascular phase of contrast-enhanced intraoperative ultrasound. This stems from the limitation of administering Sonazoid; all focal liver lesions could not be examined during the vascular phase when a patient had three or more focal liver lesions. More tumors can be examined during the vascular phase of contrast-enhanced intraoperative ultrasound if the dose of Sonazoid used in one injection is reduced, although this aspect necessitates further validation. Nonetheless, the assessment of the diagnostic ability of this modality seemed appropriate because the differences of proportion of tumors reached statistical significance regarding the findings during the vascular phase. Another drawback may be the specific setting of the study. Only patients who were scheduled to undergo surgery for HCC were the subjects. Thus, the results concerning findings in both the vascular and Kupffer phase may not be applicable to all patients with focal liver lesions. In conclusion, contrast-enhanced intraoperative ultrasound using Sonazoid is useful for estimating the histologic grade of HCC, and, in particular, findings during the Kupffer phase strongly correlate with histologic grade. References 1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 0. Int J Cancer 1; 94: Ikeguchi M, Sato N, Hirooka Y, Kaibara N. Computerized nuclear morphometry of hepatocellular carcinoma and its relation to proliferative activity. J Surg Oncol 1998; 68: Shimada M, Takenaka K, Taguchi K, et al. Prognostic factors after repeat hepatectomy for recurrent hepatocellular carcinoma. Ann Surg 1998; 227: Wayne JD, Lauwers GY, Ikai I, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg 2; 235: Sato M, Watanabe Y, Lee T, et al. Well-differentiated hepatocellular carcinoma: clinicopathological features and results of hepatic resection. Am J Gastroenterol 1995; 90: Takayama T, Makuuchi M, Hirohashi S, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology 1998; 28: Esnaola NF, Lauwers GY, Mirza NQ, et al. Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation. J Gastrointest Surg 2; 6: Kim BK, Han KH, Park YN, et al. Prediction of microvascular invasion before curative resection of hepatocellular carcinoma. J Surg Oncol 8; 97: Gaiani S, Celli N, Piscaglia F, et al. Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. J Hepatol 4; 41: AJR:196, June 2011
8 10. Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. Eur Radiol 4; 14: Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 4; 232: Catala V, Nicolau C, Vilana R, et al. Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 7; 17: Yanagisawa K, Moriyasu F, Miyahara T, Yuki M, Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 7; 33: Kindberg GM, Tolleshaug H, Roos N, Skotland T. Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres. Cell Tissue Res 3; 312: Watanabe R, Matsumura M, Munemasa T, Fujimaki M, Suematsu M. Mechanism of hepatic parenchyma-specific contrast of microbubble-based contrast agent for ultrasonography: microscopic studies in rat liver. Invest Radiol 7; 42: Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrastenhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 8; 51[suppl 1]: Imai Y, Murakami T, Yoshida S, et al. Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading. Hepatology 0; 32: Lim JH, Choi D, Cho SK, et al. Conspicuity of hepatocellular nodular lesions in cirrhotic livers at ferumoxides-enhanced MR imaging: importance of Kupffer cell number. Radiology 1; 220: Kitamura H, Kawasaki S, Nakajima K, Ota H. Correlation between microbubble contrast-enhanced color Doppler sonography and immunostaining for Kupffer cells in assessing the histopathologic grade of hepatocellular carcinoma: preliminary results. J Clin Ultrasound 2; 30: Inoue T, Kudo M, Hatanaka K, et al. Imaging of hepatocellular carcinoma: qualitative and quantitative analysis of postvascular phase contrast-enhanced ultrasonography with Sonazoid comparison with superparamagnetic iron oxide magnetic resonance images. Oncology 8; 75[suppl 1]: Korenaga K, Korenaga M, Furukawa M, Yamasaki T, Sakaida I. Usefulness of Sonazoid contrastenhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 9; 44: Bru C, Maroto A, Bruix J, et al. Diagnostic accuracy of fine-needle aspiration biopsy in patients with hepatocellular carcinoma. Dig Dis Sci 1989; 34: Caturelli E, Solmi L, Anti M, et al. Ultrasound guided fine needle biopsy of early hepatocellular carcinoma complicating liver cirrhosis: a multicentre study. Gut 4; 53: Forner A, Vilana R, Ayuso C, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 8; 47: Pawlik TM, Gleisner AL, Anders RA, Assumpcao L, Maley W, Choti MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility. Ann Surg 7; 245: [No authors listed]. Terminology of nodular hepatocellular lesions: International Working Party. Hepatology 1995; 22: Kokudo N, Bandai Y, Imanishi H, et al. Management of new hepatic nodules detected by intraoperative ultrasonography during hepatic resection for hepatocellular carcinoma. Surgery 1996; 119: Jang HJ, Kim TK, Burns PN, Wilson SR. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation. Radiology 7; 244: Liu GJ, Xu HX, Lu MD, et al. Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. Br J Radiol 7; 80: Tanaka M, Nakashima O, Wada Y, Kage M, Kojiro M. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996; 24: Inoue T, Kudo M, Watai R, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 5; 40: Torzilli G, Palmisano A, Del Fabbro D, et al. Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? A prospective cohort study of our experience. Ann Surg Oncol 7; 14: Yang H, Liu GJ, Lu MD, Xu HX, Xie XY. Evaluation of the vascular architecture of hepatocellular carcinoma by micro flow imaging: pathologic correlation. J Ultrasound Med 7; 26: Watanabe R, Matsumura M, Chen CJ, Kaneda Y, Ishihara M, Fujimaki M. Gray-scale liver enhancement with Sonazoid (NC100100), a novel ultrasound contrast agent detection of hepatic tumors in a rabbit model. Biol Pharm Bull 3; 26: Fan ZH, Chen MH, Dai Y, et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology. AJR 6; 186: Amano S, Ebara M, Yajima T, et al. Assessment of cancer cell differentiation in small hepatocellular carcinoma by computed tomography and magnetic resonance imaging. J Gastroenterol Hepatol 3; 18: Sakabe K, Yamamoto T, Kubo S, et al. Correlation between dynamic computed tomographic and histopathological findings in the diagnosis of small hepatocellular carcinoma. Dig Surg 4; 21: Monzawa S, Ichikawa T, Nakajima H, Kitanaka Y, Omata K, Araki T. Dynamic CT for detecting small hepatocellular carcinoma: usefulness of delayed phase imaging. AJR 7; 188: Yoon SH, Lee JM, So YH, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR 9; 193: 1581; [web]w482 W489 AJR:196, June
RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI. Chapter 1
RICCARDO LENCIONI,CLOTILDE DELLA PINA, LAURA CROCETTI,DANIA CIONI Chapter 1 Impact of European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB) Guidelines on the Use of Contrast
More informationEvaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients
Original Article Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients Wei Wu, Minhua Chen, Kun Yan, Yin Dai,
More informationDetection and Characterization of Hepatocellular Carcinoma by Imaging
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S136 S140 Detection and Characterization of Hepatocellular Carcinoma by Imaging OSAMU MATSUI Department of Imaging Diagnosis and Interventional Radiology,
More information116 ( 3. 0 cm), 146 ( 3. 0 cm) 42 48 ; 48, 5 CT 38 (79. 2 %),, ;6 ;4 3 1. 5 cm, 1 2. 2 cm 27 (56. 0 %) ; 14 (29. 0 %) 2 4,17 1 2, 4, 42, 87. 5 %(42/ 48 ), ; CT, ; ; ; Early diagnosis of small hepatocellular
More informationMædica - a Journal of Clinical Medicine
Mædica - a Journal of Clinical Medicine ORIGINAL PAPERS How Often Hepatocellular Carcinoma Has a Typical Pattern in Contrast Enhanced Ultrasound? Alina MARTIE, MD; Ioan SPOREA, MD, PhD; Roxana SIRLI, MD,
More informationInnovations in HCC Imaging: MDCT/MRI
Innovations in HCC Imaging: MDCT/MRI Anthony E. Cheng, M.D. Cardinal MRI Center Cardinal Santos Medical Center, Wilson Street, San Juan Innovations in HCC Imaging: Goals/Objectives MDCT/MRI Learn the diagnostic
More informationS th US Contrast
S3-1 Comparison of CEUS and CECT or CEMRI in Assessment of Tumor Vascularity and Response to Thermal Ablation in Patients with Hepatocellular Carcinoma: A Multi-centre Study in China Ming-De LU, 1 Xiao-Ling
More informationINTRODUCTION. Key Words: Contrast enhanced ultrasonography; Liver masses. ORiginal Article
Gut and Liver, Vol. 8, No. 3, May 2014, pp. 292-297 ORiginal Article Clinically Useful Diagnostic Tool of Contrast Enhanced Ultrasonography for Focal Liver Masses: Comparison to Computed Tomography and
More informationContrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases
The British Journal of Radiology, 85 (2012), 351 357 Contrast-enhanced ultrasound for characterisation of hepatic lesions appearing non-hypervascular on CT in chronic liver diseases H MARUYAMA, MD, PhD,
More informationHepatocellular carcinoma (HCC) is a malignant liver neoplasm
Diagn Interv Radiol 2011; 17:328 333 Turkish Society of Radiology 2011 ABDOMINAL IMAGING ORIGINAL ARTICLE Correlation of dynamic multidetector CT findings with pathological grades of hepatocellular carcinoma
More informationThe role of contrast enhanced ultrasound (ceus) in the assessment of liver nodules in patients with cirrhosis
Review Medical Ultrasonography 2010, Vol. 12, no. 2, 145-149 The role of contrast enhanced ultrasound (ceus) in the assessment of liver nodules in patients with cirrhosis Mirela Dănilă, Ioan Sporea, Roxana
More informationFocal Hepatic Lesions: Contrast- Enhancement Patterns at Pulse-Inversion Harmonic US using a Microbubble Contrast Agent
Focal Hepatic Lesions: Contrast- Enhancement Patterns at Pulse-Inversion Harmonic US using a Microbubble Contrast Agent Eun-A Kim, MD Kwon-Ha Yoon, MD Young Hwan Lee, MD Hye Won Kim, MD Seon Kwan Juhng,
More informationGastrointestinal Imaging Original Research
Gastrointestinal Imaging Original Research Jang et al. Multiphase CT in HCC Gastrointestinal Imaging Original Research Hyun-Jung Jang 1 Tae Kyoung Kim 1 Korosh Khalili 1 Leyla Yazdi 1 Ravi Menezes 1 Seong
More informationFocus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View. Masamichi Kojiro
Focus on Dysplastic Nodules and Early Hepatocellular Carcinoma: An Eastern Point of View Masamichi Kojiro Although increasing numbers of equivocal nodular lesions have been detected in patients with liver
More informationMRI of Small Hepatocellular Carcinoma: Typical Features Are Less Frequent Below a Size Cutoff of 1.5 cm
Gastrointestinal Imaging Original Research Choi et al. MRI of Small HCC Gastrointestinal Imaging Original Research Moon Hyung Choi 1 Joon-Il Choi 1 Young Joon Lee 1 Michael Yong Park 1 Sung Eun Rha 1 Chandana
More informationHCC and mass effect. Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? What you need to know about AFP.
Hepatocellular cancer: what if the AFP is rising but no lesion seen on imaging? Arun J Sanyal M.B.B.S., M.D. Charles Caravati Professor of Medicine Virginia Commonwealth University Imaging features used
More informationHistologic Characteristics of Hepatocellular Carcinomas Showing Atypical Enhancement Patterns on 4-Phase MDCT Examination
Original Article http://dx.doi.org/10.3348/kjr.2012.13.5.586 pissn 1229-6929 eissn 2005-8330 Korean J Radiol 2012;13(5):586-593 Histologic Characteristics of Hepatocellular Carcinomas Showing Atypical
More informationHCC e CEUS. Prof. A. Giorgio. Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico
HCC e CEUS Prof. A. Giorgio Direttore IX UOC di Malattie Infettive ad Indirizzo Ecointerventistico The natural history of compensated cirrhosis due to hepatitis C virus: a 17 year cohort study of 214 patients
More informationThe Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk
2013 67 4 239 244 The Diagnosis of Hypovascular Hepatic Lesions Showing Hypo-intensity in the Hepatobiliary Phase of Gd-EOB- DTPA-enhanced MR Imaging in High-risk Patients for Hepatocellular Carcinoma
More informationIntrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1
Intrahepatic Sarcomatoid Cholangiocarcinoma with Portal Vein Thrombosis: A Case Report 1 Jae-Hoon Lim, M.D., Jin Woong Kim, M.D., Suk Hee Heo, M.D., Yong Yeon Jeong, M.D., Heoung Keun Kang, M.D. A 53-year-old
More informationLIVER IMAGING TIPS IN VARIOUS MODALITIES. M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly
LIVER IMAGING TIPS IN VARIOUS MODALITIES M.Vlychou, MD, PhD Assoc. Professor of Radiology University of Thessaly Hepatocellular carcinoma is a common malignancy for which prevention, screening, diagnosis,
More informationEarly detection and characterization of hepatocellular. Early Detection and Curative Treatment of Early-Stage Hepatocellular Carcinoma
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2005;3:S144 S148 Early Detection and Curative Treatment of Early-Stage MASATOSHI KUDO Department of Gastroenterology and Hepatology, Kinki University School of
More informationModern liver imaging techniques - A new era in liver ultrasound
Modern liver imaging techniques - A new era in liver ultrasound Yuko Kono, M.D., Ph.D. Clinical Professor Departments of Medicine and Radiology University of California, San Diego San Diego, USA How to
More informationdoi: /hepr Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version)
bs_bs_banner Hepatology Research 2016; 46: 3 9 doi: 10.1111/hepr.12542 Special Report Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version) Masatoshi Kudo, Kazuomi Ueshima,
More informationMultiphasic MDCT Enhancement Pattern of Hepatocellular Carcinoma Smaller Than 3 cm in Diameter: Tumor Size and Cellular Differentiation
Gastrointestinal Imaging Original Research Yoon et al. MDCT of Hepatocellular Carcinoma Gastrointestinal Imaging Original Research Soon Ho Yoon 1 Jeong Min Lee 1,2 Young Ho So 1 Sung Hyun Hong 3 Soo Jin
More informationMRI for HCC surveillance and reporting: LI-RADS. Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA
MRI for HCC surveillance and reporting: LI-RADS Donald G. Mitchell, M.D. Thomas Jefferson University Philadelphia, PA Cirrhotic Nodules Regenerative Nodule Atypical Nodule Hyperplastic Nodule Dysplastic
More informationCompute-aided Differentiation of Focal Liver Disease in MR Imaging
1063 Compute-aided Differentiation of Focal Liver Disease in MR Imaging Xuejun Zhang a, Masayuki Kanematsu b, Hiroshi Fujita c, Takeshi Hara c, Hiroshi Kondo b, Xiangrong Zhou c, Wenguang Li a and Hiroaki
More informationImage Guidance Improves Localization of Sonographically Occult Colorectal Liver Metastases
Image Guidance Improves Localization of Sonographically Occult Colorectal Liver Metastases Universe Leung a, Amber L. Simpson a,b, Lauryn B. Adams a, William R. Jarnagin a, Michael I. Miga b, and T. Peter
More informationThe Contribution of Contrast Enhanced Ultrasound for the characterization of benign liver lesions in clinical practice a monocentric experience
Original papers Med Ultrason 2012, Vol. 14, no. 4, 283-287 The Contribution of Contrast Enhanced Ultrasound for the characterization of benign liver lesions in clinical practice a monocentric experience
More informationUtility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2013;11:187 192 Utility of Adding Primovist Magnetic Resonance Imaging to Analysis of Hepatocellular Carcinoma by Liver Dynamic Computed Tomography YOUNG JOO JIN,*
More informationHEPATIC METASTASES. We can state 3 types of metastases depending on their treatment options:
HEPATIC METASTASES 1. Definition Metastasis means the spread of cancer. Cancerous cells can separate from the primary tumor and enter the bloodstream or the lymphatic system (the one that produces, stores,
More informationTimothy L. Miao 1, Ania Z. Kielar 2,3, Rebecca M. Hibbert 2, Nicola Schieda 2,3
DOES LESION T1 SIGNAL INTENSITY RELATIVE TO LIVER PARENCHYMA PREDICT VISIBILITY ON ULTRASOUND? A clinical tool to determine feasibility of ultrasound-guided percutaneous interventions Timothy L. Miao 1,
More informationImaging-Based Diagnostic Systems for Hepatocellular Carcinoma
Gastrointestinal Imaging Review Cruite et al. Imaging-Based Diagnosis of Hepatocellular Carcinoma Gastrointestinal Imaging Review FOCUS ON: Irene Cruite 1 An Tang 2 Claude B. Sirlin 3 Cruite I, Tang A,
More informationDiscrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound
The British Journal of Radiology, 85 (2012), 1376 1384 Discrimination between neoplastic and non-neoplastic lesions in cirrhotic liver using contrast-enhanced ultrasound 1,2 H-X XU, MD, PhD, 2 M-D LU,
More informationState of the Art Imaging for Hepatic Malignancy: My Assignment
State of the Art Imaging for Hepatic Malignancy: My Assignment CT vs MR vs MRCP Which one to choose for HCC vs Cholangiocarcinoma What special protocols to use for liver tumors Role of PET and Duplex US
More informationContrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma
Contrast-Enhanced Ultrasound in Assessing Therapeutic Response in Ablative Treatments of Hepatocellular Carcinoma Zeno Sparchez 1, Pompilia Radu 1, Ofelia Anton 1, Mihai Socaciu 2, Radu Badea 1 1) 3 rd
More informationAlthough hepatocellular carcinoma (HCC) with lymph node
ORIGINAL ARTICLE Impact of Histologically Confirmed Lymph Node Metastases on Patient Survival After Surgical Resection for Hepatocellular Carcinoma Report of a Japanese Nationwide Survey Kiyoshi Hasegawa,
More informationGuidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma
EJC SUPPLEMENTS 6 (2008) 1 8 available at www.sciencedirect.com journal homepage: www.ejconline.com Guidelines for the use of contrast-enhanced ultrasound in hepatocellular carcinoma Riccardo Lencioni
More informationInternational Journal of Current Medical Sciences- Vol. 6, Issue,, pp , June, 2016 A B S T R A C T
ISSN: 2320-8147 International Journal of Current Medical Sciences- Vol. 6, Issue,, pp. 122-126, June, 2016 COMPUTED TOMOGRAPHY IN HEPATIC METASTASES Ananthakumar P and Adaikkappan M., Available online
More informationDefect Reperfusion Imaging with Sonazoid : A Breakthrough in Hepatocellular Carcinoma
2235-1795/16/0051-0001$39.50/0 1 Editorial Defect Reperfusion Imaging with Sonazoid : A Breakthrough in Hepatocellular Carcinoma Prof. M. Kudo Editor Liver Cancer The basic concept of contrast-enhanced
More informationHepatocellular Carcinoma. Markus Heim Basel
Hepatocellular Carcinoma Markus Heim Basel Outline 1. Epidemiology 2. Surveillance 3. (Diagnosis) 4. Staging 5. Treatment Epidemiology of HCC Worldwide, liver cancer is the sixth most common cancer (749
More informationINTRODUCTION. Yun Ku Cho 1, Ju Won Kim 1, Mi Young Kim 1, and Hyeon Je Cho 2
Gut and Liver, Vol. 12,. 1, January 2018, pp. 79-85 ORiginal Article n-hypervascular Hypointense dules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense
More informationAlice Fung, MD Oregon Health and Science University
Alice Fung, MD Oregon Health and Science University Disclosure Comments The speaker Alice Fung, MD Has relevant financial relationships to disclose. Received honorarium from (Guerbet). This individual
More informationInvited Re vie W. Analytical histopathological diagnosis of small hepatocellular nodules in chronic liver diseases
Histol Histopathol (1 998) 13: 1077-1 087 http://www.ehu.es/histoi-histopathol Histology and Histopathology Invited Re vie W Analytical histopathological diagnosis of small hepatocellular nodules in chronic
More informationSmall Liver Nodule Detection With a High-Frequency Transducer in Patients With Chronic Liver Disease
SE SERIES Small Liver Nodule Detection With a High-Frequency Transducer in Patients With hronic Liver Disease Report of 3 cases nnemarie uadu, MD, Monique. Meyer, MD We report 3 cases in which small liver
More informationEvangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece
Evangelos Chartampilas Bioclinic Hospital Thessaloniki, Greece Hepatospecificcontrast agents Gadobenate dimeglumine (Multihance) Gadoxeticacid (Primovist) 3-5% liver uptake 50% liver uptake Hepatobiliary
More informationOriginal Article Gastrointestinal Imaging
Original Article Gastrointestinal Imaging Radiofrequency ablation (RFA) has been accepted as a promising technique for treating small hepatocellular carcinomas (HCCs) (1-3). Among the various guiding modalities
More informationLiver Perfusion Analysis New Frontiers in Dynamic Volume Imaging. Case Study Brochure Chang Gung Memorial Hospital.
New Frontiers in Dynamic Volume Imaging dynamic volume CT Case Study Brochure Chang Gung Memorial Hospital http://www.toshibamedicalsystems.com Toshiba Medical Systems Corporation 2010-2011. All rights
More informationAvailable online at Journal of the Chinese Medical Association 74 (2011) 62e68. Original Article
Available online at www.sciencedirect.com Journal of the Chinese Medical Association 74 (2011) 62e68 Original Article Characterization of hyperintense nodules on T1-weighted liver magnetic resonance imaging:
More informationRadiology of hepatobiliary diseases
GI cycle - Lecture 14 436 Teams Radiology of hepatobiliary diseases Objectives 1. To Interpret plan x-ray radiograph of abdomen with common pathologies. 2. To know the common pathologies presentation.
More informationClinical evaluation of new diagnostic modalities of EUS for pancreatobiliary diseases
Digestive Endoscopy 2015; 27 (Suppl. 1): 60 67 doi: 10.1111/den.12454 Clinical evaluation of new diagnostic modalities of EUS for pancreatobiliary diseases Contrast-enhanced harmonic endoscopic ultrasonography
More informationDifferentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase
Differentiating small arterial only enhancing hepatocellular carcinoma from nontumorous arteroportal shunt with an emphasis on the precontrast phase Poster No.: C-0739 Congress: ECR 2015 Type: Scientific
More informationU ltrasonography (US) is reported to be the primary
401 LIVER Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A C F Dietrich, A Ignee, J Trojan,
More informationHEPATO-BILIARY IMAGING
HEPATO-BILIARY IMAGING BY MAMDOUH MAHFOUZ MD PROF.OF RADIOLOGY CAIRO UNIVERSITY mamdouh.m5@gmail.com www.ssregypt.com CT ABDOMEN Indications Patient preparation Patient position Scanogram Fasting 4-6 hours
More informationdimeglumine enhanced MRI.
Hepatobiliary Imaging Ricci et al. Sonography of Benign Liver Lesions Paolo Ricci 1 Andrea Laghi Vito Cantisani Pasquale Paolantonio Sara Pacella Elisa Pagliara Federico Arduini Valerio Pasqualini Francesca
More informationRadiological Reasoning: Incidentally Discovered Liver Mass
AJR Integrative Imaging LIFELONG LEARNING FOR RADIOLOGY This Radiological Reasoning article is available for SAM credit and CME credits when completed with the additional educational material provided
More informationShearWave elastography in lymph nodes
ShearWave elastography in lymph nodes Poster No.: B-0158 Congress: ECR 2015 Type: Authors: Keywords: DOI: Scientific Paper F. Houari, O. Lucidarme, J. Gabarre, F. Charlotte, C. Pellot- Barakat, M. Lefort,
More informationObjectives. HCC Incidence and Mortality. Disclosure Statement HCC. Imaging of Hepatocellular Carcinoma. Treatment of Hepatocellular Carcinoma
Imaging of Hepatocellular Carcinoma and the use of LI RADS Treatment of Hepatocellular Carcinoma Aaron D. Anderson, D.O. AOCR April 2015 Objectives Show how the use of LI RADS can simplify the diagnosis
More informationAMSER Case of the Month: June 2018
AMSER Case of the Month: June 2018 64 year old male undergoing evaluation for liver transplant By Timothy Morgan, MS IV Lake Erie College of Osteopathic Medicine Jonathan Potts, MD Interventional Radiology,
More informationCLINICAL LIVER, PANCREAS, AND BILIARY TRACT
GASTROENTEROLOGY 2008;134:1908 1916 BILIARY TRACT Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular Carcinoma TAKEAKI ISHIZAWA, KIYOSHI HASEGAWA, TAKU AOKI,
More informationWenxin Xu, Harvard Medical School Year III. Gillian Lieberman, MD
August 2011 Wenxin Xu, Harvard Medical School Year III Primary liver tumor, typically in setting of chronic liver disease Viral hepatitis (HBV, HCV) in 80% of cases 2nd leading cause of cancer death worldwide
More informationEvaluation of Blood Flow Signal in Small Hepatic Nodules by Color Doppler Ultrasonography
Evaluation of Blood Flow Signal in Small Hepatic Nodules by Color Doppler Ultrasonography Junji Furuse, Masahiko Iwasaki, Masahiro Yoshino, Masaru Konishi, Noriaki Kawano, Taira Kinoshita and Munemasa
More informationTechnological advancements improve the sensitivity of CEUS diagnostics
Technological advancements improve the sensitivity of CEUS diagnostics. Martegani, MD, L. iani, MD Department of Diagnostic Imaging, Valduce Hospital, Como, Italy Characterization with Ultrasound B C D
More informationLiver Cancer And Tumours
Liver Cancer And Tumours What causes liver cancer? Many factors may play a role in the development of cancer. Because the liver filters blood from all parts of the body, cancer cells from elsewhere can
More informationEffective Health Care Program
Comparative Effectiveness Review Number 143 Effective Health Care Program Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma Executive Background and Objectives Hepatocellular carcinoma
More informationPROPOSTA DI UN NUOVO ALGORIMO PER LA DIAGNOSI ECOGRAFICA DELLE MALATTIE CRONICHE DEL FEGATO
PROPOSTA DI UN NUOVO ALGORIMO PER LA DIAGNOSI ECOGRAFICA DELLE MALATTIE CRONICHE DEL FEGATO A. Giorgio Direttore del servizio di Ecografia Interventistica Istituto Clinico S.Rita -IRCCS -Atripalda (Avellino)
More informationUS-Guided Radiofrequency Ablation of Hepatic Focal Lesions
US-Guided Radiofrequency Ablation of Hepatic Focal Lesions Poster No.: C-2219 Congress: ECR 2011 Type: Scientific Exhibit Authors: D. Armario Bel, A. PLA, F. TERREL, X. Serres; BARCELONA/ES Keywords: Neoplasia,
More informationEmbolotherapy for Cholangiocarcinoma: 2016 Update
Embolotherapy for Cholangiocarcinoma: 2016 Update Igor Lobko,MD Chief, Division Vascular and Interventional Radiology Long Island Jewish Medical Center GEST 2016 Igor Lobko, M.D. No relevant financial
More informationManagement of Rare Liver Tumours
Gian Luca Grazi Hepato-Biliary-Pancreatic Surgery National Cancer Institute Regina Elena Rome Fibrolamellar Carcinoma Mixed Hepato Cholangiocellular Carcinoma Hepatoblastoma Carcinosarcoma Primary Hepatic
More informationUtility of 18 F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer
Utility of F-FDG PET/CT in metabolic response assessment after CyberKnife radiosurgery for early stage non-small cell lung cancer Ngoc Ha Le 1*, Hong Son Mai 1, Van Nguyen Le 2, Quang Bieu Bui 2 1 Department
More informationThe Frequency and Significance of Small (15 mm) Hepatic Lesions Detected by CT
535 Elizabeth C. Jones1 Judith L. Chezmar Rendon C. Nelson Michael E. Bernardino Received July 22, 1991 ; accepted after revision October 16, 1991. Presented atthe annual meeting ofthe American Aoentgen
More informationAre we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting?
Rajani Sharma, PGY1 Geriatrics CRC Project, 12/19/13 Are we adequately screening at-risk patients for hepatocellular carcinoma in the outpatient setting? A. Study Purpose and Rationale Hepatocellular carcinoma
More informationByung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital
Byung Ihn Choi, M.D. Department of Radiology Seoul National University Hospital CEUS & US Elastography : Contents CEUS Introduction Contrast agents & imaging Clinical application US Video WS Summary US
More informationSimplifying liver assessment in internal medicine
Ultrasound Customer story Simplifying liver assessment in internal medicine Philips Affiniti ultrasound for elastography and contrast-enhanced ultrasound (CEUS) Where Sonography Institute, Uster, Switzerland
More informationRADIATION SEGMENTECTOMY. Robert J Lewandowski, MD
RADIATION SEGMENTECTOMY Robert J Lewandowski, MD Robert Lewandowski, M.D. Consultant/Advisory Board: Cook Medical, LLC, Arsenal, BTG International, Boston Scientific Corp., ABK Reference Unlabeled/Unapproved
More informationClinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe
2235-1795/15/0042-0085$39.50/0 85 Editorial Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan, United States, and Europe Prof. M. Kudo Editor Liver Cancer Introduction Hepatocellular
More informationULTRASOUND IN CHRONIC LIVER DISEASE
ULTRASOUND IN CHRONIC LIVER DISEASE Prof. Ioan Sporea, MD, PhD Head of Department of Gastroenterology and Hepatology University of Medicine and Pharmacy, Timişoara, Romania WFUMB Center of Education (COE),
More informationMalignant Breast Masses Pak Armed Forces Med J 2014; 64 (1): 4-8 ORIGINAL ARTICLES. Sadaf Aziz, Arfan-ul-Haq*, Asad Maqbool Ahmad
ACCURACY OF THE DOPPLER RESISTIVE INDEX IN THE DIAGNOSIS OF MALIGNANT BREAST MASSES Sadaf Aziz, Arfan-ul-Haq*, Asad Maqbool Ahmad Combined Military Hospital Khuzdar, *AFIRI Rawalpindi ABSTRACT Objective:
More informationSuperparamagnetic Iron Oxide Enhanced Magnetic Resonance Images of Hepatocellular Carcinoma: Correlation With Histological Grading
Superparamagnetic Iron Oxide Enhanced Magnetic Resonance Images of Hepatocellular Carcinoma: Correlation With Histological Grading YASUHARU IMAI, 1 TAKAMICHI MURAKAMI, 5 SHIGEYUKI YOSHIDA, 2 MASAHIRO NISHIKAWA,
More informationImaging of liver and pancreas
Imaging of liver and pancreas.. Disease of the liver Focal liver disease Diffusion liver disease Focal liver disease Benign Cyst Abscess Hemangioma FNH Hepatic adenoma HCC Malignant Fibrolamellar carcinoma
More informationIntraoperative staging of GIT cancer using Intraoperative Ultrasound
Intraoperative staging of GIT cancer using Intraoperative Ultrasound Thesis For Fulfillment of MSc Degree In Surgical Oncology By Abdelhalim Salah Abdelhalim Moursi M.B.B.Ch (Cairo University ) Supervisors
More informationImaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound
The British Journal of Radiology, 83 (2010), 411 418 Imaging features of hepatic angiomyolipomas on real-time contrast-enhanced ultrasound 1 Z WANG, MD, 1 H-X XU, MD, PhD, 1 X-Y XIE, MD, PhD, 1 X-H XIE,
More informationImaging in gastric cancer
Imaging in gastric cancer Gastric cancer remains a deadly disease because of late diagnosis. Adenocarcinoma represents 90% of malignant tumors. Diagnosis is based on endoscopic examination with biopsies.
More informationIndex terms: Liver, CT Liver neoplasm, CT. Korean J Radiol 2005;6: Received February 21, 2005; accepted after revision May 24, 2005.
Depiction of Viable Tumor in Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: Multiphasic Helical CT with Review of the Previous Serial CT Images Kyung Mi Jang, MD 1 Dongil Choi,
More informationCommon and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review
Review Article Common and unusual CT and MRI manifestations of pancreatic adenocarcinoma: a pictorial review Min-Jie Yang, Su Li, Yong-Guang Liu, Na Jiao, Jing-Shan Gong Department of Radiology, Shenzhen
More informationWith the widespread use of hepatic imaging, liver masses
2B: Liver Assessment of the Liver Mass: What Do You Need to Know? With the widespread use of hepatic imaging, liver masses are detected either unexpectedly or in the course of screening for liver cancer
More informationImaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma
Imaging techniques to characterize spleen involvement in patients with Hodgkin lymphoma Marco Picardi, MD Ematologia, Azienda Ospedaliera Universitaria Federico II, Naples, Italy 5th International Workshop
More informationThe UGent Institutional Repository is the electronic archiving and dissemination platform for
biblio.ugent.be The UGent Institutional Repository is the electronic archiving and dissemination platform for all UGent research publications. Ghent University has implemented a mandate stipulating that
More informationMultiple Primary Quiz
Multiple Primary Quiz Case 1 A 72 year old man was found to have a 12 mm solid lesion in the pancreatic tail by computed tomography carried out during a routine follow up study of this patient with adult
More informationManagement of hepatocellular carcinoma should consider both tumor factors and background liver factors
Hepatocellular Carcinoma Column: Editorial Management of hepatocellular carcinoma should consider both tumor factors and background liver factors Shuji Nomoto, Mitsuhiro Hishida, Yoshikuni Inokawa, Hiroyuki
More informationPrediction of Microvascular Invasion of Hepatocellular Carcinoma: Preoperative CT and Histopathologic Correlation
Gastrointestinal Imaging Original Research Gastrointestinal Imaging Original Research Chen-Te Chou 1,2 Ran-Chou Chen 2,3 Wei-Chan Lin 2,4 Chih-Jan Ko 5 Chia-Bang Chen 1 Yao-Li Chen 5,6 Chou CT, Chen RC,
More informationContrast Enhanced Ultrasound of Parenchymal Masses in Children
Contrast Enhanced Ultrasound of Parenchymal Masses in Children Sue C Kaste, DO On behalf of Beth McCarville, MD St. Jude Children s Research Hospital Memphis, TN Overview Share St. Jude experience with
More informationHistologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination
Histologic characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on 4-phase multidetector CT examination Injoong Kim Department of Medicine The Graduate School, Yonsei
More informationEarly View Article: Online published version of an accepted article before publication in the final form.
: Online published version of an accepted article before publication in the final form. Journal Name: International Journal of Case Reports and Images (IJCRI) Type of Article: Case Series Title: Ultrasound
More informationHepatocellular Carcinoma: Diagnosis and Management
Hepatocellular Carcinoma: Diagnosis and Management Nizar A. Mukhtar, MD Co-director, SMC Liver Tumor Board April 30, 2016 1 Objectives Review screening/surveillance guidelines Discuss diagnostic algorithm
More informationGeneral summary GENERAL SUMMARY
General summary GENERAL SUMMARY In Chapter 2.1 the long-term results and prognostic factors of radiofrequency ablation (RFA) for unresectable colorectal liver metastases (CRLM) in a single center with
More informationThe Focal Hepatic Lesion: Radiologic Assessment
The Focal Hepatic Lesion: Radiologic Assessment Kevin Kuo, Harvard Medical School Year III Our Patient: PS 67 y/o female w/ long history of alcohol use Drinking since age 18, up to one bottle of wine/day
More informationHepatocellular adenomas (HCAs) are uncommon primary benign tumours. They are constantly monoclonal tumours.
Hepatocellular adenoma: Evaluation with contrast enhanced ultrasound, MRI And Correlation with pathologic and phenotypic classification. About 26 lesions. Poster No.: C-1561 Congress: ECR 2011 Type: Scientific
More informationTitle: What is the role of pre-operative PET/PET-CT in the management of patients with
Title: What is the role of pre-operative PET/PET-CT in the management of patients with potentially resectable colorectal cancer liver metastasis? Pablo E. Serrano, Julian F. Daza, Natalie M. Solis June
More information